Eficacia de la asociación de lacosamida en neuralgia del trigémino

Sanabria Sanchinel, Abel Alejandro; Livengood Ordóñez, María de los Angeles.
Rev. Soc. Esp. Dolor ; 27(1): 50-52, ene.-feb. 2020.
Artículo en Español | IBECS (España) | ID: ibc-193932

Documentos relacionados

  1. Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases.
  2. Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway.
  3. Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases.
  4. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
  5. Lacosamide in trigeminal neuralgia: report of a case refractory to first- and second-generation anticonvulsants.
  6. Lacosamide add-on therapy for focal epilepsy.
  7. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
  8. Therapeutic Monitoring of Lacosamide in Japanese Patients With Epilepsy: Clinical Response, Tolerability, and Optimal Therapeutic Range.
  9. Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice.
  10. Validation of Conversion Factors for Therapeutic Drug Monitoring of Lacosamide, Lamotrigine, and Levetiracetam in Dried Capillary Blood.